Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001654954-17-009181
Filing Date
2017-10-05
Accepted
2017-10-05 17:28:42
Documents
3
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K qtxb10ka_dec312016.htm 10-K/A 657000
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31.htm EX-31 11938
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32.htm EX-32 7012
  Complete submission text file 0001654954-17-009181.txt   677120
Mailing Address P.O. BOX 4960 TUALATIN OR 97062
Business Address P.O. BOX 4960 TUALATIN OR 97062 267-880-1595
QUANTRX BIOMEDICAL CORP (Filer) CIK: 0000820608 (see all company filings)

EIN.: 330202574 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-17119 | Film No.: 171125342
SIC: 3841 Surgical & Medical Instruments & Apparatus